鐑兇寰�(f霉)鍒嗚В鍙嶆噳(y墨ng)鐨勬鍙插彲浠ヨ拷婧埌20涓栫磤50骞翠唬锛岃捣婧愪簬楂樺垎瀛愬寲瀛�(xu茅)鐮旂┒锛屾秹鍙婇噾灞偓鍖栧姂瀛樺湪涓嬬儻鐑撮洐閸电殑閲嶇祫銆傝垏鍏跺畠鍙嶆噳(y墨ng)鐩告瘮锛岃┎鍙嶆噳(y墨ng)鐢卞惈閹炽�侀帰銆侀嚂鍜岄壃鐨勯亷娓￠噾灞崱璩撻厤鍚堢墿鍌寲锛屽壇鐢�(ch菐n)鐗╁強寤㈢墿鎺掓斁灏�锛屾洿鍔犵挵(hu谩n)淇�銆傚洜姝よ寤ｆ硾鎳�(y墨ng)鐢ㄤ簬閱�(y墨)钘ュ拰鑱氬悎鐗╁伐妤�(y猫)涓��
2008骞寸櫨闈堝▉鑸嘢TREM姝ｅ紡绨界讲鎴�(zh脿n)鐣ュ悎浣滃崝(xi茅)璀�锛屽叏娆�(qu谩n)璨犺铂STREM鍦ㄤ腑鍦嬪競鍫寸殑鐢�(ch菐n)鍝侀姺鍞�銆佹妧琛�(sh霉)鎳�(y墨ng)鐢ㄨ垏鏀寔绛夊悇闋呮キ(y猫)鍕�(w霉)銆傜櫨闈堝▉濮嬬祩绉夋壙“璩囨簮鍏变韩锛屽叡鍚岀櫦(f膩)灞�”涔嬬悊蹇�銆備竴濡傛棦寰�鐨勭偤涓湅鍖栧(xu茅)琛屾キ(y猫)寤ｅぇ绉戠爺鍜岀敓鐢�(ch菐n)鐢ㄦ埗鎻愪緵鍝佽唱(zh矛)鍗撹秺鐨勬湁姗熼噾灞�銆侀厤楂�銆佸偓鍖栧姂绛夌敘(ch菐n)鍝佸強鏈嶅嫏(w霉)銆�
鈻� 鐢�(ch菐n)鍝佹帹钖�
.png)
| 鐢�(ch菐n)鍝佺法铏� |
涓嫳鏂囧悕 |
CAS |
瑕�(gu墨)鏍� |
| 42-1200 |
2,6-Diisopropylphenylimidoneophylidene molybdenum(VI) bis(t-butoxide)
2,6-浜岀暟涓欏熀浜炶兒闆欏彅涓佹哀鍩洪壃 |
126949-65-3 |
100 mg
500 mg
2 g |
| 42-1205 |
2,6-Diisopropylphenylimidoneophylidene molybdenum(VI) bis (hexafluorot-butoxide) SCHROCK'S CATALYST
2锛�6-浜岀暟涓欏熀鑻叞浜炶兒 鏂板�间簩鐑洐宸卞熀鍙斾竵閱囬壃 |
139220-25-0 |
100 mg
500 mg
2 g |
| 42-1212 |
2,6-Diisopropylphenylimidoneophylidene[racemic-BIPHEN] molybdenum(VI), min. 97% rac-SCHROCK-HOVEYDA CATALYST
2,6-浜岀暟涓欏熀鑻熀浜炶兒[racemic-BIPHEN]閴� |
300344-02-9 |
100 mg
500 mg |
.png)
.png)
.png)
| 鐢�(ch菐n)鍝佺法铏� |
涓嫳鏂囧悕 |
CAS |
瑕�(gu墨)鏍� |
| 08-2045 |
racemic-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol, 99% rac-BIPHEN H2
(+/-)-3,3'-浜�-鍙斾竵-5,5',6,6'-鍥涚敳鍩轰簩鑱�(li谩n)鑻�-2,2'-浜岄唶 |
101203-31-0 |
5 g
25 g |
| 19-1600 |
(R)-(-)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-di-t-butyl-1,1'-bi-2-naphthol, dipotassium salt
(R)-(-)-5,5',6,6',7,7',8,8'-鍏茎鍩�-3,3'-浜屽彅涓佸熀-1,1'-鑱�(li谩n)-2-钀橀唶浜岄墍楣� |
350683-75-9 |
100 mg
500 mg |
| 42-1210 |
2,6-Diisopropylphenylimido neophylidenemolybdenum(VI) bis(trifluoromethanesulfonate)
dimethoxyethane adduct
2,6-浜岀暟涓欏熀鑻熀浜炴皑鍩烘柊妞嶄簩鐑壃锛圴I锛夐洐锛堜笁姘熺敳纾洪吀閰級鐨勪簩鐢叉哀
鍩轰箼鐑峰姞鍚堢墿 |
126949-63-1 |
100 mg
500 mg |
鈻� 鐩搁棞(gu膩n)鐢�(ch菐n)鍝�
| 鐢�(ch菐n)鍝佺法铏� |
涓嫳鏂囧悕 |
CAS |
绲�(ji茅)妲�(g貌u)寮� |
瑕�(gu墨)鏍� |
| 42-1213 |
2,6-Diisopropylphenylimidoneophylidene[(R)-(+)-BIPHEN]molybdenum
(VI), min. 97%
(R) SCHROCK-HOVEYDA CATALYST
2,6-浜岀暟涓欏熀鑻熀浜炴皑鍩哄彅涓佸熀浜炶嫰鍩篬(R)-(+)-BIPHEN]閴�(鈪�) |
329735-77-5 |
N/A |
100 mg
500 mg |
| 42-1214 |
2,6-Diisopropylphenylimidoneophylidene[(S)-(-)-BIPHEN]molybdenum
(VI), min. 97%
(S) SCHROCK-HOVEYDA CATALYST
2,6-浜岀暟涓欏熀鑻熀浜炴皑鍩哄彅涓佸熀浜炶嫰鍩篬(S)-(-)-BIPHEN]閴�(鈪�) |
205815-80-1 |
N/A |
100 mg
500 mg |
| 08-2046 |
(R)-(+)-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol, 99% (R)-BIPHEN H2
(R)-(+)-5,5'锛�6,6'-鍥涚敳鍩�-3锛�3'-浜屽彅涓佸熀-1锛�1'-鑱�(li谩n)鑻�-2锛�2'-浜岄唶 |
329735-68-4 |
N/A |
100 mg
500 mg
2 g |
| 08-2047 |
(S)-(-)-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol, 99% (S)-BIPHEN H2
(S)-(-)-5,5'锛�6,6'-鍥涚敳鍩�- 3锛�3'-浜屽彅涓佸熀- 1锛�1'-鑱�(li谩n)鑻�- 2锛�2' -浜岄唶 |
205927-03-3 |
N/A |
100 mg
500 mg
2 g |
| 19-1601 |
(S)-(+)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-di -t-butyl-1,1'-bi-2-naphthol, dipotassium salt
(S)-(+)-5,5',6,6',7,7',8,8'-鍏茎鍩�-3,3'-浜屽彅涓佸熀-1,1'-鑱�(li谩n)-2-钀橀唶浜岄墍楣� |
N/A |
N/A |
100 mg
500 mg |
鈻� 鐧鹃潏濞佹湁姗熺敘(ch菐n)鍝佺窔
• 閶伴瑭﹀姂 • 瓒呭共婧跺姂 • 淇濊瑭�鍔� • 鏈夋纭艰│鍔� • 璨撮噾灞偓鍖栧姂鍙婇厤楂�
• 绺悎瑭﹀姂 • 鎷嗗垎瑭﹀姂 • 鎵嬫�т腑闁撻珨 • 灏忓垎瀛愰洔鐠�(hu谩n)涓枔楂� • 楂樼礆楣典唬鍖栧悎鐗�